Beam Therapeutics
Price & Volume
Stats
See more52W Range | $13.52-$35.25 |
Market Cap | $2.7B |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $60.2M |
Revenue Growth (YoY) | -28.1% |
Gross Profit (12 Mos) | -$301.4M |
Diluted EPS | -$4.84 |
News
See moreYahoo Finance • 11 days ago
Peek Under The Hood: VB Has 14% Upside
Yahoo Finance • 25 days ago
Interesting BEAM Put And Call Options For January 2028
Yahoo Finance • 2 months ago
Cathie Wood's ARK ETF bolsters biotech, trims defense stock
Yahoo Finance • 2 months ago
Prime Medicine’s SWOT analysis: gene editing firm faces cash crunch amid promising tech
About
CEO | Mr. John M. Evans M.B.A. |
Address | 238 Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 509 |
